PIH31 COST-EFFECTIVENESS ANALYSIS OF REGORAFENIB AS A...

PIH31 COST-EFFECTIVENESS ANALYSIS OF REGORAFENIB AS A SECOND-LINE THERAPY IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA IN CHINA

Xiao, D., Zhu, S., Sun, W., Xuan, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.831
Date:
May, 2019
File:
PDF, 721 KB
english, 2019
Conversion to is in progress
Conversion to is failed